Author

Vladimir Torchilin

University Professor, Northeastern University - Cited by 87,372

Biography

Vladimir P. Torchilin is a University Distinguished Professor and Director, Center for Pharmaceutical Biotechnology and Nanomedicine, Northeastern University, Boston. He graduated from the Moscow University with MS in Chemistry, and obtained there his Ph.D. and D.Sc. in Polymer Chemistry and Chemistry of Physiologically Active Compounds in 1971 and 1980, respectively. In 1991, Dr. Torchilin joined MGH/Harvard Medical School as the Head of Chemistry Program, Center for Imaging and Pharmaceutical Research, and Associate Professor of Radiology. Since 1998 Dr. Torchilin is with Northeastern University. He was the Chair of the Department of Pharmaceutical Sciences in 1998-2008.
Title
Cited by
Year
Recent advances in tumor targeting via EPR effect for cancer treatment
MA Subhan, SSK Yalamarty, N Filipczak, F Parveen, VP TorchilinJournal of personalized medicine 11 (6), 571, 2021202
151
2021
siRNA based drug design, quality, delivery and clinical translation
MA Subhan, VP TorchilinNanomedicine: Nanotechnology, Biology and Medicine 29, 102239, 2020202
78
2020
Cell penetrating peptides: A versatile vector for co-delivery of drug and genes in cancer
MM Khan, N Filipczak, VP TorchilinJournal of Controlled Release 330, 1220-1228, 2021202
71
2021
Hypoxia-sensitive micellar nanoparticles for co-delivery of siRNA and chemotherapeutics to overcome multi-drug resistance in tumor cells
U Joshi, N Filipczak, MM Khan, SA Attia, V TorchilinInternational Journal of Pharmaceutics 590, 119915, 2020202
41
2020
Folate targeted lipid chitosan hybrid nanoparticles for enhanced anti-tumor efficacy
MM Khan, A Madni, N Filipczak, J Pan, M Rehman, N Rai, SA Attia, ...Nanomedicine: Nanotechnology, Biology and Medicine 28, 102228, 2020202
30
2020
Charge reversible hyaluronic acid-modified dendrimer-based nanoparticles for siMDR-1 and doxorubicin co-delivery
X Zhang, J Pan, M Yao, LP Mendes, C Sarisozen, S Mao, VP TorchilinEuropean Journal of Pharmaceutics and Biopharmaceutics 154, 43-49, 2020202
29
2020
Multifunctional polymeric micellar nanomedicine in the diagnosis and treatment of cancer
N Raval, R Maheshwari, H Shukla, K Kalia, VP Torchilin, RK TekadeMaterials Science and Engineering: C 126, 112186, 2021202
29
2021
Developments in treatment methodologies using dendrimers for infectious diseases
N Filipczak, SSK Yalamarty, X Li, F Parveen, V TorchilinMolecules 26 (11), 3304, 212
20
2021
Targeted delivery of combination therapeutics using monoclonal antibody 2C5-modified immunoliposomes for cancer therapy
R Narayanaswamy, VP TorchilinPharmaceutical research 38, 429-450, 2021202
19
2021
Advances in siRNA delivery strategies for the treatment of MDR cancer
MA Subhan, SA Attia, VP TorchilinLife sciences 274, 119337, 2021202
18
2021
Lipid-based drug delivery systems in regenerative medicine
N Filipczak, SSK Yalamarty, X Li, MM Khan, F Parveen, V TorchilinMaterials 14 (18), 5371, 2021202
16
2021
An update on dual targeting strategy for cancer treatment
YD Taghipour, A Zarebkohan, R Salehi, F Rahimi, VP Torchilin, ...Journal of Controlled Release 349, 67-96, 2022202
15
2022
Effect of polymers attached to lipid headgroups on properties of liposomes
VP TorchilinHandbook of nonmedical applications of liposomes, 263-284, 2023202
13
2023
Neutrophils as an emerging therapeutic target and tool for cancer therapy
MA Subhan, VP TorchilinLife Sciences 285, 119952, 2021202
12
2021
Co-delivery of siRNA and chemotherapeutic drug using 2C5 antibody-targeted dendrimer-based mixed micelles for multidrug resistant cancers
SSK Yalamarty, N Filipczak, X Li, TV Pathrikar, C Cotter, VP TorchilinPharmaceutics 14 (7), 1470, 2022202
10
2022
Hypoxia-sensitive drug delivery to tumors
N Filipczak, U Joshi, SA Attia, IB Fridman, S Cohen, T Konry, V TorchilinJournal of Controlled Release 341, 431-442, 2022202
9
2022
Biodistribution of surface-modified liposomes and particles
VP Torchilin, VS TrubetskoyMicroparticulate Systems for the Delivery of Proteins and Vaccines, 243-2, 2020202
7
2020
Liquid crystalline nanodispersion functionalized with cell-penetrating peptides improves skin penetration and anti-inflammatory effect of lipoic acid after in vivo skin …
PM Campos, FG Praca, SV Mussi, SA Figueiredo, MCA Fantini, ...Drug Delivery and Translational Research 10, 1810-1828, 2020202
6
2020
Investigation of eutectic mixtures of fatty acids as a novel construct for temperature-responsive drug delivery
F Parveen, A Madni, VP Torchilin, M Rehman, T Jamshaid, N Filipczak, ...International journal of nanomedicine, 2413-2434, 2022202
6
2022
Liposomal Co-delivery of PD-L1 siRNA/Anemoside B4 for enhanced combinational immunotherapeutic effect
X Li, X Zhou, J Liu, J Zhang, Y Feng, F Wang, Y He, A Wan, N Filipczak, ...ACS Applied Materials & Interfaces 14 (2), 28439-2844, 2022202
5
2022

Referred From: https://scholar.google.com/citations?user=OKSa6s8AAAAJ&hl=en

Cited by
Citations 87372
h-index 130
i10-index 540
Recommended Journals
Open Access Journals